1. Aberle D, Adams A, Berg C, Black W, Clapp J, Fagers- trom R, et al. Reduced lung-cancer mortality with low- dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
2. Gould MK. Lung-cancer screening with low-dose computed tomography. N Engl J Med. 2014;371:1813-20.
3. Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015; 191:19-33.
4. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330-8.
5. Pinsky PF, Berg CD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen. 2012;19:154-6.
6. De Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, Seijo LM, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132:1932-8.
7. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178:738-44.
8. de-Torres JP, Casanova C, Marín JM, Zagaceta J, Al- caide AB, Seijo LM, et al. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study. Respir Med. 2013;107:702-7.
9. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986;105:503-7.
10. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380-6.
11. Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quanti- tative emphysema analysis. Chest. 2010;138:1295-302.
12. Powell HA, Iyen-Omofoman B, Baldwin DR, Hubbard RB, Tata LJ. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis. J Thorac Oncol. 2013;8:6-11.
13. De Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, et al. Lung cancer in patients with chronic obstructive pulmonary disease– incidence and predicting factors. Am J Respir Crit Care Med. 2011; 184:913-9.
14. Sanchez-Salcedo P, Berto J, De-Torres JP, Campo A, Alcaide AB, Bastarrika G, et al. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP). Arch Bronconeumol. 2015; 51:169-76.
15. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003;163:1475-80.
16. Wasswa-Kintu S, Gan WQ, Man SFP, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60:570-5.
17. Henschke CI, Yip R, Boffetta P, Markowitz S, Miller A, Hanaoka T, et al. CT screening for lung cancer: Importance of emphysema for never smokers and smokers. Lung Cancer. 2015;88:42-7.
18. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176: 285-90.
19. Zulueta JJ, Wisnivesky JP, Henschke CI, Yip R, Farooqi AO, McCauley DI, et al. Emphysema scores predict death from COPD and lung cancer. Chest. 2012;141: 1216-23.
20. Young RP, Hopkins RJ. Lung cancer risk prediction to select smokers for screening CT–letter. Cancer Prev Res (Phila). 2012;5:697–8; author reply 699.
21. Sanchez-Salcedo P, Wilson DO, De-Torres JP, Weissfeld JL, Berto J, Campo A, et al. Improving selection criteria for lung cancer screening: the potential role of emphysema. Am J Respir Crit Care Med. 2015. [Epub ahead of print.]
22. Wang Y, Midthun DE, Wampfler JA, Deng B, Stoddard SM, Zhang S, et al. Trends in the proportion of patients with lung cancer meeting screening criteria. JAMA.
23. de-Torres JP, Wilson DO, Sanchez-Salcedo P, Weissfeld JL, Berto J, Campo A, et al. Lung cancer in COPD patients: development and validation of the COPD LUng Cancer Screening Score (COPD-LUCSS). Am J Respir Crit Care Med. 2015;191:285-91
24. Lowry KP, Gazelle GS, Gilmore ME, Johanson C, Munshi V, Choi SE, et al. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer. 2015. [Epub ahead of print.]
25. Choong CK, Meyers BF, Battafarano RJ, Guthrie TJ, Davis GE, Patterson GA, et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg. 2004; 127:1323-31.
26. WangW,XuZ,XiongX,YinW,XuX,ShaoW,etal. Video-assisted thoracoscopic lobectomy for non-small cell lung cancer in patients with severe chronic obstructive pulmonary disease. J Thorac Dis. 2013;5 Suppl 3: S253-9.
27. Ashraf H, Saghir Z, Dirksen A, Pedersen JH, Thomsen LH, Døssing M, et al. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax. 2014;69:574-9.
28. Slatore CG, Baumann C, Pappas M, Humphrey LL. Smoking behaviors among patients receiving computed tomography for lung cancer screening: Systematic review in support of the U.S. Preventive services task force. Ann Am Thorac Soc. 2014;11(4):619-27.
29. Tønnesen P. Smoking cessation and COPD. Eur Respir Rev. 2013;22:37-43.
30. Dhariwal J, Tennant RC, Hansell DM, Westwick J, Walker C, Ward SP, et al. Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT ima- ging. Chest. 2014;145:1006-15.2015;313:853-5.